Exodus Point Capital Management, LP Intercept Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$9.99 - $18.71 $1.06 Million - $1.99 Million	-106,132 Reduced 75.15%	35,087 $651,000
Q2 2023 Aug 10, 2023	BUY	$9.17 - $19.29 $583,771 - $1.23 Million	63,661 Added 82.08%	141,219 $1.56 Million
Q1 2023 May 11, 2023	SELL	$12.53 - $21.71 $5.68 Million - $9.83 Million	-453,009 Reduced 85.38%	77,558 $1.04 Million
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $5.19 Million - $7.2 Million	446,628 Added 532.09%	530,567 $6.56 Million
Q3 2022 Nov 10, 2022	BUY	$12.21 - $19.7 $1.02 Million - $1.65 Million	83,939 New	83,939 $1.17 Million
Q2 2022 Aug 19, 2022	SELL	$11.23 - $19.59 $390,186 - $680,654	-34,745 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$13.37 - $17.79 $1.64 Million - $2.19 Million	-122,918 Reduced 77.96%	34,745 $565,000
Q4 2021 Feb 11, 2022	BUY	$14.28 - $19.53 $1.84 Million - $2.52 Million	129,030 Added 450.63%	157,663 $2.57 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $233,794 - $368,419	17,998 Added 169.23%	28,633 $425,000
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $114,713 - $181,790	-7,420 Reduced 41.1%	10,635 $212,000
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $16,894 - $32,993	-874 Reduced 4.62%	18,055 $417,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $463,381 - $803,914	18,929 New	18,929 $468,000
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $1.6 Million - $2.19 Million	-40,941 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $1.91 Million - $3.77 Million	40,941 New	40,941 $1.96 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $199,546 - $273,564	-3,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $124,743 - $193,570	1,604 Added 89.31%	3,400 $271,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $164,926 - $216,741	1,796 New	1,796 $201,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account